ADSTILADRIN Early Utilization and Outcomes in the Real World Setting

NCT06026332 · clinicaltrials.gov ↗
TERMINATED
Status
202
Enrollment
INDUSTRY
Sponsor class

Stopped An internal audit identified major inconsistencies and missing data in key registry fields, including primary outcomes. These issues mean we can no longer ensure the validity of the primary endpoints.

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals